Stereocontrolled Access to ( Z )‐Heteroatom‐Substituted Fluoroalkenes Through Fluorine‐Directed, Hydrogen‐Bond‐Assisted Elimination
Angewandte Chemie · 09.11.2026 · 138 (46)
DOI: 10.1002/ange.7450551 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie, online erschienen am 26.09.2026. Verfasst von Zhaoxuan Xu und 3 weiteren Autor:innen. Die Arbeit nennt 89 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
A general method for the stereocontrolled synthesis of ( Z )‐1,2‐heteroatom‐substituted monofluoroethylenes is described. The reaction proceeds via the Michael addition of N‐, P‐, and S‐centered nucleophiles to 1‐fluorovinyl sulfonium ylide ( Ylide‐VF ) under mild conditions, followed by an E2 process. This general protocol exhibits broad functional group tolerance and significant application potential, as demonstrated by the late‐stage functionalization of bioactive molecules and oligopeptides. Mechanistic investigations reveal that an intramolecular hydrogen bond within the Michael addition intermediate is the key stereocontrolling element, dictating the observed Z ‐selectivity.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, Z., Li, Z., Xu, S., & Shen, Q. (2026). Stereocontrolled Access to ( Z )‐Heteroatom‐Substituted Fluoroalkenes Through Fluorine‐Directed, Hydrogen‐Bond‐Assisted Elimination. Angewandte Chemie, 138(46). https://doi.org/10.1002/ange.7450551
Vancouver
Xu Z, Li Z, Xu S, Shen Q. Stereocontrolled Access to ( Z )‐Heteroatom‐Substituted Fluoroalkenes Through Fluorine‐Directed, Hydrogen‐Bond‐Assisted Elimination. Angewandte Chemie. 2026;138(46). doi:10.1002/ange.7450551
BibTeX
@article{Xu2026,
author = {Xu, Zhaoxuan and Li, Zimeng and Xu, Songsong and Shen, Qilong},
title = {Stereocontrolled Access to ( Z )‐Heteroatom‐Substituted Fluoroalkenes Through Fluorine‐Directed, Hydrogen‐Bond‐Assisted Elimination},
journal = {Angewandte Chemie},
year = {2026},
volume = {138},
number = {46},
doi = {10.1002/ange.7450551}
}
EUVIMED